RACIAL/ETHNIC DIFFERENCES IN USE OF ADJUVANT HORMONAL THERAPY AMONG WOMEN WITH ESTROGEN RECEPTOR-POSITIVE (ER plus ) BREAST CANCER

被引：0
|
作者：
Livaudais, J. [1 ]
Li, C. [1 ]
John, E. [1 ]
Daly, M. [1 ]
Terry, M. [1 ]
Buys, S. [1 ]
Thompson, B. [1 ]
LaCroix, A. [1 ]
Habel, L. [1 ]
Coronado, G. [1 ]
机构：
[1] Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA
来源：
AMERICAN JOURNAL OF EPIDEMIOLOGY | 2010年 / 171卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：S23 / S23
页数：1
相关论文
共 50 条
  • [21] Use of endocrine therapy for estrogen receptor-positive breast cancer among American Indians and Alaska natives
    Engelking, Marta
    Marmor, Schelomo
    Burjak, Mohamad
    Hinojos, Madeleine
    Lloyd, Whitney
    Switalla, Kayla M.
    Tuttle, Todd M.
    BREAST CANCER RESEARCH AND TREATMENT, 2023, 198 (02) : 187 - 195
  • [22] Use of endocrine therapy for estrogen receptor-positive breast cancer among American Indians and Alaska natives
    Marta Engelking
    Schelomo Marmor
    Mohamad Burjak
    Madeleine Hinojos
    Whitney Lloyd
    Kayla M. Switalla
    Todd M. Tuttle
    Breast Cancer Research and Treatment, 2023, 198 : 187 - 195
  • [23] Adjuvant chemotherapy for elderly women with hormone receptor-positive breast cancer: An old(er) problem
    Schott, A
    Hayes, DF
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (23) : 4660 - 4661
  • [24] Risk of early recurrence among postmenopausal women with estrogen receptor-positive early breast cancer treated with adjuvant tamoxifen
    Kennecke, Hagen
    McArthur, Heather
    Olivotto, Ivo A.
    Speers, Caroline
    Bajdik, Chris
    Chia, Stephen K.
    Ellard, Susan
    Norris, Brian
    Hayes, Malcolm
    Barnett, Jeff
    Gelmon, Karen A.
    CANCER, 2008, 112 (07) : 1437 - 1444
  • [25] Randomized comparison of adjuvant toremifene (Tor) versus tamoxifen (Tam) for postmenopausal women with node-positive (N plus ), estrogen receptor-positive (ER plus ) early stage breast cancer
    不详
    BREAST, 2005, 14 : S38 - S38
  • [26] Avoidance of Negative Results in Adjuvant Endocrine Therapy Trials for Estrogen Receptor-Positive Breast Cancer
    Goncalves, Rodrigo
    Reinert, Tomas
    Ellis, Matthew J.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (23) : 2718 - +
  • [27] Non-initiation of adjuvant hormonal therapy in women with hormone receptor-positive breast cancer: The Breast Cancer Quality of Care Study (BQUAL)
    Neugut, Alfred I.
    Hillyer, Grace Clarke
    Kushi, Lawrence H.
    Lamerato, Lois
    Leoce, Nicole
    Nathanson, S. David
    Ambrosone, Christine B.
    Bovbjerg, Dana H.
    Mandelblatt, Jeanne S.
    Magai, Carol
    Tsai, Wei-Yann
    Jacobson, Judith S.
    Hershman, Dawn L.
    BREAST CANCER RESEARCH AND TREATMENT, 2012, 134 (01) : 419 - 428
  • [28] Non-initiation of adjuvant hormonal therapy in women with hormone receptor-positive breast cancer: The Breast Cancer Quality of Care Study (BQUAL)
    Alfred I. Neugut
    Grace Clarke Hillyer
    Lawrence H. Kushi
    Lois Lamerato
    Nicole Leoce
    S. David Nathanson
    Christine B. Ambrosone
    Dana H. Bovbjerg
    Jeanne S. Mandelblatt
    Carol Magai
    Wei-Yann Tsai
    Judith S. Jacobson
    Dawn L. Hershman
    Breast Cancer Research and Treatment, 2012, 134 : 419 - 428
  • [29] Hormonal therapy confers clinically relevant benefit in women with low estrogen receptor-positive breast tumor
    Zhang, T.
    Ho, B.
    Chan, P. M. Y.
    Tan, E. Y.
    ANNALS OF ONCOLOGY, 2018, 29 : 9 - 9
  • [30] HER-2/neu overexpression and response to oophorectomy plus tamoxifen adjuvant therapy in estrogen receptor-positive premenopausal women with operable breast cancer
    Love, RR
    Duc, NB
    Havighurst, TC
    Mohsin, SK
    Zhang, Q
    DeMets, DL
    Allred, DC
    JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (03) : 453 - 457
12345